[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-335169-105":59,"doc-detail-335169-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","prognostic-significance-of-tumor-suppressor-protein-p53-in-prostate-cancer-abstract","Prognostic significance of tumor suppressor protein p53 in prostate cancer - Abstract","","P53 gene mutations are among the most frequent genetic alterations in many cancers, and in prostate cancer they are linked to poor outcomes, tumor progression, and aggressiveness. This study retrospectively evaluated p53 protein expression by immunohistochemistry on prostate cancer cases diagnosed between 2012 and 2022. Automated analysis assessed staining proportion and intensity; expression was classified as abnormal when totally negative or overexpressed (≥50% positive cells).",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/prognostic-significance-of-tumor-suppressor-protein-p53-in-prostate-cancer-abstract/335169/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/prognostic-significance-of-tumor-suppressor-protein-p53-in-prostate-cancer-abstract/335169.png","ImageObject",300,407,{"name":92,"@type":93},"Asher","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-23","2026-09-21",true,{"@type":102,"interactionType":103,"userInteractionCount":44},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"How was p53 expression evaluated in prostate cancer cases?","Question",{"text":112,"@type":113},"p53 expression was assessed using automated immunohistochemistry with a monoclonal p53 antibody. The study measured the proportion of positive cells and the intensity of staining for each case.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"What criteria defined abnormal p53 expression?",{"text":117,"@type":113},"Abnormal p53 expression was defined as either completely negative (protein loss) or overexpressed, with expression in ≥50% of positive cells.",{"name":119,"@type":110,"acceptedAnswer":120},"What prognostic relationships were found for p53 abnormalities?",{"text":121,"@type":113},"Abnormal p53 expression occurred in 42% of cases and was significantly associated with androgen resistance. Patients with abnormal expression also showed higher Gleason scores and higher-grade ISUP in a subset of cases.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},335169,1790017045,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":44,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":24,"language":139,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":140,"faqs":141,"seo_title":142,"seo_description":67,"update_tm":143,"read_time":144,"preview_page_count":4},687197207639,"https://ap-avatar.wpscdn.com/davatar_a8503ba1806abce46bf441b54a3ca4cd","ARTICLE ORIGINAL  \nPrognostic significance of tumor suppressor protein p53 in prostate cancer Valeur pronostique de la protéine p53 dans le cancer de la prostate  \nSarra Ben Rejeb1, Nadia Kouki1, Sirine Elfekih1, Ines Cherif1, Hassen Khouni2  \n1. Department of pathology. Internal security forces hospital, Tunis, Tunisia.  \n2. Department of urology. Internal security forces hospital, Tunis, Tunisia.  \nAbstrAct  \nBackround: The p53 gene mutation is one of the most common genetic alterations in many cancers. In prostate cancer (PCa), it has been associated with a poor prognosis, tumor progression and aggressiveness. P53 mutation induces an abnormal protein expression in related tissues.  \nAim: This study aimed to assess p53 expression using immunohistochemistry in PCa and to discuss its prognostic value.  \nMethods: We have retrospectively collected all cases of PCa diagnosed in our pathology department between 2012 and 2022. An automatized immunohistochemical analysis was performed using monoclonal p53 antibody. For each case, we assessed the proportion of positive cells and the intensity of staining. P53 expression was considered abnormal when it was totally negative or overexpressed (>=50% of positive cells) .  \nResults: Twenty-four cases have been selected. Abnormal p53 expression was found in 42% of cases (P53 was overexpressed in 6cases and totally negative in 4 cases) . Mean age of patients with p53 abnormal expression was 70years old. Patients with p53 abnormal expression had Gleason score >7 in 5 cases, ISUP grade >2 in 3 cases, peri-neural invasion in 8cases, capsule invasion in 9cases. All patients with p53 overexpression developed androgen resistance (p\u003C0 .01) .  \nConclusion: An aberrant expression profile of the p53 protein was observed in 42% of cases, and a statistically significant association was found with androgen resistance. Our results suggest a potential prognostic role of p53 in PCa.  \nKey words: prostate carcinoma, p53, immunohistochemistry  \nrésumé  \nIntroduction: Les mutations du gène p53 sont parmi les anomalies moléculaires les plus fréquentes dans les cancers et notamment du cancer de la prostate et semblent être associées à un mauvais pronostic.  \nObjectif: Etudier l’expression de la protéine p53 par immunohistochimie et de discuter sa valeur pronostique.  \nMéthodes: Il s’agit d’une étude rétrospective descriptive ayant porté sur les cas d’adénocarcinome prostatique diagnostiqués dans notre service de 2012 à 2022. Une étude immunohistochimique automatisée a été effectuée à l’aide de l’anticorps anti-p53 . Pour chaque cas, nous avons évalué le pourcentage de cellules marquées et l’intensité du marquage. Le profil d’expression était aberrant en absence totale d’expression ouen cas de surexpression (>=50% de noyaux marqués) .  \nRésultats: Vingt-quatre cas ont été inclus. Un profil d’expression aberrant du p53 a été observé dans 42% des cas (surexpression dans 6cas, absence d’expression dans 4cas) . L’âge moyen de ces patients était de 70ans. Parmi ces cas, le score de Gleason était >7 dans 5cas, le grade ISUP>2 dans 3 cas, une invasion péri-nerveuse dans 8cas et une invasion capsulaire dans 8cas. Tous ces patients ont développé une résistance aux androgènes (p\u003C0 .01) .  \nConclusion: Un profil d’expression aberrant de la protéine p53 a été observé dans 42% des cas et une association statistiquement significativea été retrouvée avec la résistance aux androgènes.  \nMots clés: carcinome, prostate, p53, immunohistochimie  \nCorrespondance Sarra Ben Rejeb  \nDepartment of pathology. Internal security forces hospital, Tunis, Tunisia.  \nEmail: [sarrabenrejeb88@yahoo.fr](sarrabenrejeb88@yahoo.fr)  \nLA TUNISIE MEDICALE-2024; Vol 102 (02): 111-115  \nThis article is distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License (CC BY-NC-ND 4.0) which permits non-commercial use production, reproduction and distribution of the work without further permission, provi","cbCaivSp9OPIVu9A","https://ap.wps.com/l/cbCaivSp9OPIVu9A","pdf",518254,"English","# Methods\n## Immunohistochemical analysis\n# Results\n## Association with clinicopathological parameters\n# Conclusion","[{\"question\":\"How was p53 expression evaluated in prostate cancer cases?\",\"answer\":\"p53 expression was assessed using automated immunohistochemistry with a monoclonal p53 antibody. The study measured the proportion of positive cells and the intensity of staining for each case.\"},{\"question\":\"What criteria defined abnormal p53 expression?\",\"answer\":\"Abnormal p53 expression was defined as either completely negative (protein loss) or overexpressed, with expression in ≥50% of positive cells.\"},{\"question\":\"What prognostic relationships were found for p53 abnormalities?\",\"answer\":\"Abnormal p53 expression occurred in 42% of cases and was significantly associated with androgen resistance. Patients with abnormal expression also showed higher Gleason scores and higher-grade ISUP in a subset of cases.\"}]","Prognostic significance of tumor suppressor protein p53 in prostate cancer - Abstract | PDF",1790009882,13]